Want to see AU:C79 full AI Analyst Report?
C79 Stock Chart & Stats
AU$7.33
-AU$0.13(-2.61%)
At close: 4:00 PM EST
AU$7.33
-AU$0.13(-2.61%)
Day’s Range― - ―
52-Week RangeAU$4.89 - AU$10.13
Previous CloseN/A
Volume18.61K
Average Volume (3M)347.84K
Market Cap
AU$678.04M
Enterprise ValueAU$786.05M
Total Cash (Recent Filing)AU$21.57M
Total Debt (Recent Filing)AU$55.10M
Price to Earnings (P/E)―
Beta1.66
Next Earnings
Aug 31, 2026EPS Estimate
<0.01Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.04
Shares Outstanding116,501,300
10 Day Avg. Volume301,690
30 Day Avg. Volume347,840
Financial Highlights & Ratios
PEG Ratio-0.07
Price to Book (P/B)2.73
Price to Sales (P/S)8.20
P/FCF Ratio-9.05
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
AU$8.90Price Target Upside21.42% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
EPS Forecast (FY)0.07
Revenue Forecast (FY)AU$115.04M
Bulls Say, Bears Say
Bulls Say
Exceptional Gross MarginAn exceptionally high gross margin (99.97%) implies Chrysos's PhotonAssay has low incremental costs and strong product-level pricing power. This durable margin cushion supports reinvestment in R&D and service infrastructure as deployments scale, improving long-term unit economics.
Reported Revenue GrowthReported 19.11% revenue growth signals growing commercial adoption of PhotonAssay technology. Given the company's revenue model tied to unit deployments and ongoing throughput/service fees, sustained top-line expansion helps absorb fixed costs and move the business toward more predictable recurring revenue.
Low Financial LeverageA low debt-to-equity ratio (0.13) gives Chrysos meaningful financial flexibility to fund deployments and weather operating volatility without heavy interest burdens. This conservative capital structure reduces refinancing risk and supports continued investment in commercial rollouts and product development.
Bears Say
Negative Net MarginNegative net margin (-12.44%) and a declining EBIT margin show Chrysos has not yet converted strong gross margins into operating profitability. Persistent operating losses threaten equity levels and require sustained margin improvement or higher revenue scaling to deliver durable shareholder returns.
Negative Free Cash FlowNegative free cash flow and weak cash conversion (OCF-to-net-income 0.20) constrain Chrysos's ability to self-fund installations and support services. Over the medium term this elevates reliance on external financing, increasing dilution or funding risk and limiting the pace of commercial scaling.
Negative Return On EquityA negative ROE (-4.15%) indicates the company is not generating returns from its equity base. Persistently negative ROE complicates capital raising and signals that current business economics do not yet produce acceptable shareholder returns without operational improvement or scale-driven profitability.
Chrysos Corp. Ltd. News
C79 FAQ
What was Chrysos Corp. Ltd.’s price range in the past 12 months?
Chrysos Corp. Ltd. lowest share price was AU$4.89 and its highest was AU$10.13 in the past 12 months.
What is Chrysos Corp. Ltd.’s market cap?
Chrysos Corp. Ltd.’s market cap is AU$678.04M.
When is Chrysos Corp. Ltd.’s upcoming earnings report date?
Chrysos Corp. Ltd.’s upcoming earnings report date is Aug 31, 2026 which is in 57 days.
How were Chrysos Corp. Ltd.’s earnings last quarter?
Chrysos Corp. Ltd. released its earnings results on Feb 17, 2026. The company reported AU$0.006 earnings per share for the quarter, beating the consensus estimate of AU$0 by AU$0.006.
Is Chrysos Corp. Ltd. overvalued?
According to Wall Street analysts Chrysos Corp. Ltd.’s price is currently Undervalued.
Does Chrysos Corp. Ltd. pay dividends?
Chrysos Corp. Ltd. does not currently pay dividends.
What is Chrysos Corp. Ltd.’s EPS estimate?
Chrysos Corp. Ltd.’s EPS estimate is <0.01.
How many shares outstanding does Chrysos Corp. Ltd. have?
Chrysos Corp. Ltd. has 116,501,300 shares outstanding.
What happened to Chrysos Corp. Ltd.’s price movement after its last earnings report?
Chrysos Corp. Ltd. reported an EPS of AU$0.006 in its last earnings report, beating expectations of AU$0. Following the earnings report the stock price went up 2.987%.
Which hedge fund is a major shareholder of Chrysos Corp. Ltd.?
Currently, no hedge funds are holding shares in AU:C79
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Chrysos Corp. Ltd. Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
AU$8.90 (21.42% Upside)
AU$8.90 (21.42% Upside)
Blogger Sentiment
Bullish
AU:C79 Sentiment 100%
Sector Average ―
Sector Average ―
Insider Transactions
Sold Shares
Worth AU$2.7M over
the Last 3 Months
the Last 3 Months
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
55.08%
12-Months-Change
Fundamentals
Return on Equity
-2.46%
Trailing 12-Months
Asset Growth
16.34%
Trailing 12-Months
Company Description
Chrysos Corp. Ltd.
Chrysos Corporation Limited is dedicated to creating and delivering advanced solutions for the mining industry. Established in 2016 and based in Adelaide, Australia, the company's flagship product is PhotonAssay. This innovative technology enables the accurate and efficient analysis of elements such as gold, silver, and copper, among others.
C79 Stock 12 Month Forecast
Average Price Target
AU$8.90
▲(21.42% Upside)
Technical Analysis
Pointerra
―
Aerometrex Ltd.
―
Vection Technologies Ltd.
―
UUV Aquabotix Ltd.
―
Nuix Ltd.
―
Options Prices
Currently, No data available
---